drugset / Trial / NCT06925997

Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery

NCT06925997

Phase 0 Recruiting 18 enrolled Hvidovre University Hospital
NaSingle-groupOpen-labelBasic science

Summary

Non-randomized, open-label, parallel-group clinical study evaluating the effects of endogenous bile acids on changes in plasma fibroblast growth factor-19 (FGF-19) and glucose metabolism by extended depletion of circulating bile acids using colesevelam as an experimental tool in subjects operated with gastric by-pass (RYGB).

Timeline

Start
2024-05-02
Primary completion
2027-12
Completion
2028-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Colesevelam Other / unclassified 3.75 g